Lung cancer guidelines revised to include latest drugs
An estimated 173,300 Americans will be diagnosed with lung cancer this year, and 164,440 persons will die of the disease. The five-year survival rate for patients with this condition is only 14%. In an effort to improve these statistics, the National Comprehensive Cancer Network (NCCN) recently revised its Non-Small Cell Lung Cancer Clinical Practice Guidelines. The guidelines update was announced at the NCCN 9th Annual Conference, held last month in Hollywood, Fla.NCCN Clinical Practice Guidelines in Oncology are available free-of-charge on CD-ROM. They can be ordered directly from NCCN by calling 215-690-0300. The guidelines are also available on the NCCN Web site at http://www.nccn.org.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
